Sanket Shah, MD
Ophthalmology · Fresno, CANPI 1396137865
Payments from drug & device makers
Across 211 payments — averaging $266.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$17K
- Amgen$14K
- Bausch & Lomb Americas Inc.$13K
- Biotissue Holdings Inc.$4K
- Johnson & Johnson Surgical Vision, Inc.$3K
- Alcon$2K
- plus $4K from 16 others
What the payments were for
- Consulting fees$25,70046%
- Speaking & faculty fees$11,81321%
- Travel & lodging$6,73012%
- Food & beverage$11,83221%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 46 | $16,517 |
| Amgen(2 entities) | 37 | $14,049 |
| Bausch & Lomb Americas Inc. | 28 | $12,655 |
| Biotissue Holdings Inc. | 12 | $4,035 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $3,150 |
| Alcon | 27 | $1,619 |
| Sight Sciences, Inc. | 18 | $926 |
| Rxsight Inc | 9 | $827 |
| Eyepoint US, Inc. | 3 | $319 |
| AbbVie(2 entities) | 3 | $319 |
| Mallinckrodt Hospital Products Inc. | 4 | $298 |
| NEW World Medical,inc. | 3 | $285 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $282 |
| Dompe US, Inc. | 4 | $278 |
| Regeneron Healthcare Solutions, Inc. | 2 | $236 |
| Alimera Sciences, Inc. | 1 | $131 |
| Astellas Pharma US Inc | 2 | $67 |
| Carl Zeiss Meditec Cataract Technology Inc. | 1 | $66 |
| Heidelberg Engineering, Inc. | 2 | $41 |
| ANI Pharmaceuticals, Inc. | 1 | $31 |
| Sun Pharmaceutical Industries Inc. | 1 | $26 |
| Insulet Corporation | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Travoprost Intraocular Implant - iDose$13,441
- TEPEZZA$13,348
- Prokera$3,700
- AmnioGraft$3,700
- INTRALASE FS FEMTOSEC LASER$3,150
- iDoseTR$1,478
- enVista Aspire IOL$1,143
- TENEO$1,143
- STELLARIS ELITE$1,143
- iStent Infinite$740
- RXSIGHT CONTACT LENS$633
- RXSIGHT INJECTOR HANDPIECE$633
- RXSIGHT INJECTOR CARTRIDGE$633
- LIGHT ADJUSTABLE LENS (LAL)$633
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$633
- OMNI(R) SURGICAL SYSTEM (US)$391
- Hydrus Microstent$248
- SION SURGICAL INSTRUMENT$246
- EYLEA$236
- ACTHAR$234
How this compares
$56,175 in reported general payments places this provider in the 90th percentile of 2,513 ophthalmology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Brimonidine Tartrate | 28 | $1,288 |
| Acetazolamide | 19 | $1,277 |
| Prednisolone Acetate | 39 | $1,177 |
| Latanoprost | 56 | $338 |
| Timolol Maleate | 16 | $95 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Fresno
- William MaxwellFresno$758K
- Nisha AcharyaSan Francisco$33M
- David WirtaNewport Beach$18.4M
- Michael IpPasadena$10.2M
- Raymond DouglasBeverly Hills$9.7M
- Sherif El HaraziGlendale$9.2M
- Daniel SchwartzSan Francisco$8M
- Nikolas Londonla Jolla$6.1M
- Michael BerlinWest Hollywood$5.7M
- Steven JacobsonLos Angeles$4.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.